Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hot Flashes × Estetrol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Hot Flashes 1 Breast Neoplasms 1

Interventions

Venlafaxine Hydrochloride 2 Sodium Chloride 2 Magnesium Oxide 2 Gabapentin 2 Bupivacaine 2 fezolinetant 1 black cohosh root extract 1 bazedoxifene 1 Tamoxifen 1 Soybean Proteins 1 Solifenacin Succinate 1 Isoflavones 1 Hypericum extract LI 160 1 Estrogens, Conjugated (USP) 1 Estetrol 1 Daptomycin 1 Clonidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03361969 2021-06-18

Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.

Pantarhei Oncology B.V.

Phase 2 Completed

Prostatic Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡